July 11, 2023
UC San Diego Psychedelics and Health Research Initiative received the gift from philanthropist Eugene Jhong to further our understanding of the unique states of consciousness induced by DMT and how it could benefit human health.
October 26, 2022
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
December 5, 2013
A team of scientists, led by Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation…
May 14, 2014
As the single worldwide repository for the three-dimensional structures of large molecules and nucleic acids that are vital to pharmacology and bioinformatics research, the Protein Data Bank (PDB) recently archived its 100,000th molecule structure, doubling its size in just six years.
November 12, 2020
…in the Department of Pharmacology at UC San Diego School of Medicine. “So, I figured if this university has a center dedicated to cell signaling, surely UC San Diego should as well.” And so Newton, with colleague Jin Zhang, professor of pharmacology, launched the Cell Signaling Center at UC San…
February 3, 2014
Researchers at the University of California, San Diego School of Medicine have identified a protein critical to hematopoietic stem cell function and blood formation. The finding has potential as a new target for treating leukemia because cancer stem cells rely upon the same protein to regulate and sustain their growth.
October 3, 2012
Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through which some cancers mount an inflammatory response that fuels their development and growth.
August 18, 2014
In a new paper, published this week in the online early edition of PNAS, researchers at the University of California, San Diego School of Medicine conclude that aspirin has a second effect: Not only does it kill cyclooxygenase, thus preventing production of the prostaglandins that cause inflammation and pain, it…
July 21, 2016
In recognition of the Institutional Research and Academic Career Development Award (IRACDA) program at the University of California San Diego, which provides mentored training to postdocs in biomedical sciences, the National Institutes of Health has renewed its grant funding, lengthened the term and increased the number of supported postdoctoral scholars.
June 26, 2015
Researchers at University of California, San Diego School of Medicine have discovered a self-regulating loop in the Hippo pathway, a signaling channel garnering increased attention from cancer researchers due to its role in controlling organ size, cell proliferation and cell death.
